Charlotte Davison

Charlotte Davison has extensive experience serving as a Board Observer for multiple biotechnology companies, including Myricx Bio, OMass Therapeutics, Perspectum Ltd, Epsilogen Ltd, and Microbiotica. Charlotte holds a Master of Philosophy (MPhil) in Bioscience Enterprise from the University of Cambridge and a Doctor of Philosophy (PhD) in Genomics from the University of Leicester.